148 related articles for article (PubMed ID: 38019248)
21. Association between the ABCG2 C421A polymorphism and Alzheimer's disease.
Fehér Á; Juhász A; László A; Pákáski M; Kálmán J; Janka Z
Neurosci Lett; 2013 Aug; 550():51-4. PubMed ID: 23827224
[TBL] [Abstract][Full Text] [Related]
22. Effects of the
Tan Y; Cao K; Ren G; Qin Z; Zhao D; Li N; Chen X; Xia Y; Lu Y
Xenobiotica; 2020 Feb; 50(2):237-243. PubMed ID: 31021303
[TBL] [Abstract][Full Text] [Related]
23. Loss of function polymorphisms in SLCO1B1 (c.521T>C, rs4149056) and ABCG2 (c.421C>A, rs2231142) genes are associated with adverse events of rosuvastatin: a case-control study.
Merćep I; Radman I; Trkulja V; Božina T; Šimičević L; Budimir E; Ganoci L; Božina N
Eur J Clin Pharmacol; 2022 Feb; 78(2):227-236. PubMed ID: 34668025
[TBL] [Abstract][Full Text] [Related]
24. ABCG2 rs2231142 variant in hyperuricemia is modified by SLC2A9 and SLC22A12 polymorphisms and cardiovascular risk factors in an elderly community-dwelling population.
Liu J; Yang W; Li Y; Wei Z; Dan X
BMC Med Genet; 2020 Mar; 21(1):54. PubMed ID: 32183743
[TBL] [Abstract][Full Text] [Related]
25. Monoacylglycerol Lipase Inhibitor JJKK048 Ameliorates ABCG2 Transporter-Mediated Regorafenib Resistance Induced by Hypoxia in Triple Negative Breast Cancer Cells.
Puris E; Petralla S; Auriola S; Kidron H; Fricker G; Gynther M
J Pharm Sci; 2023 Sep; 112(9):2581-2590. PubMed ID: 37220829
[TBL] [Abstract][Full Text] [Related]
26. ABC-transporter gene-polymorphisms are potential pharmacogenetic markers for mitoxantrone response in multiple sclerosis.
Cotte S; von Ahsen N; Kruse N; Huber B; Winkelmann A; Zettl UK; Starck M; König N; Tellez N; Dörr J; Paul F; Zipp F; Lühder F; Koepsell H; Pannek H; Montalban X; Gold R; Chan A
Brain; 2009 Sep; 132(Pt 9):2517-30. PubMed ID: 19605531
[TBL] [Abstract][Full Text] [Related]
27. High-dose methotrexate in Egyptian pediatric acute lymphoblastic leukemia: the impact of ABCG2 C421A genetic polymorphism on plasma levels, what is next?
El Mesallamy HO; Rashed WM; Hamdy NM; Hamdy N
J Cancer Res Clin Oncol; 2014 Aug; 140(8):1359-65. PubMed ID: 24718721
[TBL] [Abstract][Full Text] [Related]
28. Impact of genetic variation in breast cancer resistance protein (BCRP/ABCG2) on sunitinib pharmacokinetics.
Mizuno T; Fukudo M; Terada T; Kamba T; Nakamura E; Ogawa O; Inui K; Katsura T
Drug Metab Pharmacokinet; 2012; 27(6):631-9. PubMed ID: 22673043
[TBL] [Abstract][Full Text] [Related]
29. Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.
Tian C; Ambrosone CB; Darcy KM; Krivak TC; Armstrong DK; Bookman MA; Davis W; Zhao H; Moysich K; Gallion H; DeLoia JA
Gynecol Oncol; 2012 Mar; 124(3):575-81. PubMed ID: 22112610
[TBL] [Abstract][Full Text] [Related]
30. Systematic screening identifies ABCG2 as critical factor underlying synergy of kinase inhibitors with transcriptional CDK inhibitors.
van der Noord VE; van der Stel W; Louwerens G; Verhoeven D; Kuiken HJ; Lieftink C; Grandits M; Ecker GF; Beijersbergen RL; Bouwman P; Le Dévédec SE; van de Water B
Breast Cancer Res; 2023 May; 25(1):51. PubMed ID: 37147730
[TBL] [Abstract][Full Text] [Related]
31. Genetic variation in the ABCG2 gene is associated with gout risk in the Chinese Han population.
Jiri M; Zhang L; Lan B; He N; Feng T; Liu K; Jin T; Kang L
Clin Rheumatol; 2016 Jan; 35(1):159-63. PubMed ID: 26506822
[TBL] [Abstract][Full Text] [Related]
32. Comprehensive Analysis of
Słomka M; Sobalska-Kwapis M; Korycka-Machała M; Dziadek J; Bartosz G; Strapagiel D
Genes (Basel); 2020 Sep; 11(10):. PubMed ID: 33003314
[TBL] [Abstract][Full Text] [Related]
33. Dysfunctional ABCG2 gene polymorphisms are associated with serum uric acid levels and all-cause mortality in hemodialysis patients.
Nakashima A; Ichida K; Ohkido I; Yokoyama K; Matsuo H; Ohashi Y; Takada T; Nakayama A; Suzuki H; Shinomiya N; Urashima M; Yokoo T
Hum Cell; 2020 Jul; 33(3):559-568. PubMed ID: 32180207
[TBL] [Abstract][Full Text] [Related]
34. Association of single nucleotide polymorphisms in MTHFR and ABCG2 with the different efficacy of first-line chemotherapy in metastatic colorectal cancer.
Zhao J; Li W; Zhu D; Yu Q; Zhang Z; Sun M; Cai S; Zhang W
Med Oncol; 2014 Jan; 31(1):802. PubMed ID: 24338217
[TBL] [Abstract][Full Text] [Related]
35. TGF-β/activin signaling promotes CDK7 inhibitor resistance in triple-negative breast cancer cells through upregulation of multidrug transporters.
Webb BM; Bryson BL; Williams-Medina E; Bobbitt JR; Seachrist DD; Anstine LJ; Keri RA
J Biol Chem; 2021 Oct; 297(4):101162. PubMed ID: 34481843
[TBL] [Abstract][Full Text] [Related]
36. Single Nucleotide Polymorphisms (SNPs) of RAD51-G172T and XRCC2-41657C/T Homologous Recombination Repair Genes and the Risk of Triple- Negative Breast Cancer in Polish Women.
Michalska MM; Samulak D; Romanowicz H; Smolarz B
Pathol Oncol Res; 2015 Sep; 21(4):935-40. PubMed ID: 25743260
[TBL] [Abstract][Full Text] [Related]
37. Single nucleotide polymorphisms (SNPs) of ERCC2, hOGG1, and XRCC1 DNA repair genes and the risk of triple-negative breast cancer in Polish women.
Smolarz B; Makowska M; Samulak D; Michalska MM; Mojs E; Wilczak M; Romanowicz H
Tumour Biol; 2014 Apr; 35(4):3495-502. PubMed ID: 24402573
[TBL] [Abstract][Full Text] [Related]
38. ABCG2 gene polymorphisms as risk factors for atorvastatin adverse reactions: a case-control study.
Mirošević Skvrce N; Macolić Šarinić V; Šimić I; Ganoci L; Muačević Katanec D; Božina N
Pharmacogenomics; 2015 Jul; 16(8):803-15. PubMed ID: 26086347
[TBL] [Abstract][Full Text] [Related]
39. Association of ABCG
Liu T; Jiang F; Liu X; Zhang H; Wang L; Liu W; Wang X
Ann Hum Genet; 2018 Sep; 82(5):325-330. PubMed ID: 29900524
[TBL] [Abstract][Full Text] [Related]
40. Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme.
Oberstadt MC; Bien-Möller S; Weitmann K; Herzog S; Hentschel K; Rimmbach C; Vogelgesang S; Balz E; Fink M; Michael H; Zeden JP; Bruckmüller H; Werk AN; Cascorbi I; Hoffmann W; Rosskopf D; Schroeder HW; Kroemer HK
BMC Cancer; 2013 Dec; 13():617. PubMed ID: 24380367
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
